GlassScriptPhysician profile
John R Gilmore
NPI 1194778928
$3,622.08
in general payments reported to CMS, 2019-2025
17 companies · $1,385 in 2025
The $1,385 reported for 2025 was more than what 87% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $129 · 2021: $218 · 2022: $804 · 2023: $139 · 2024: $124 · 2025: $1,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942 · Travel and Lodging: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.53 |
| Travel and Lodging | $706.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,487.46 | 2019-2025 | Audion Et Dilation System, Scopis Ent, Clarifix |
| Medtronic, INC. | $1,175.59 | 2025 | Propel, Nuvent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $254.64 | 2019-2025 | Jardiance |
| New World Medical,INC. | $104.64 | 2019 | |
| Aerin Medical INC. | $99.11 | 2022-2024 | |
| Glaxosmithkline, LLC. | $84.33 | 2021-2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $74.59 | 2023-2024 | Dupixent |
| Abbott Laboratories | $66.71 | 2021-2023 | Proclaim |
| Alk-Abello, INC | $62.24 | 2021 | |
| Adlon Therapeutics L.P. | $54.51 | 2020-2021 | |
| Integra Lifesciences Corporation | $33.51 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Optinose US, INC. | $33.50 | 2019-2024 | |
| Genzyme Corporation | $24.75 | 2022 | |
| Neurent Medical Limited | $20.99 | 2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Karl Storz Endoscopy-America | $18.38 | 2023 | Hopkins |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $14.88 | 2019 | |
| Merck Sharp & Dohme LLC | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gilmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.